Arginine-guanidinoacetate-creatine pathway in preterm newborns: Creatine biosynthesis in newborns

Journal of Pediatric Endocrinology and Metabolism

Volumn 26, Issue 1-2, 2013, Pages 53-60

  Lage, Sergio ^a   Andrade, Fernando ^a   Prieto, José Angel ^a   Asla, Izaskun ^b   Rodríguez, Amaya ^b   Ruiz, Nerea ^a   Echeverría, Juncal ^c   Luz Couce, María ^d   Sanjurjo, Pablo ^a   Aldámiz Echevarría, Luis ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c HOSPITAL DONOSTIA   (Spain)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Creatine; Energy metabolism; Guanidinoacetate; Immaturity; Preterm newborns

Indexed keywords

AMPICILLIN; ARGININE; CREATINE; ERYTHROMYCIN; GUANIDINOACETIC ACID; PENICILLIN DERIVATIVE; SURFACTANT; TOBRAMYCIN; VANCOMYCIN;

AMINO ACID SYNTHESIS; AMINOACIDURIA; APGAR SCORE; ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; BRAIN DEVELOPMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; NEWBORN; PARENTERAL NUTRITION; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; SIGNAL TRANSDUCTION; URINE LEVEL;

ARGININE; BIRTH WEIGHT; CASE-CONTROL STUDIES; CREATINE; FEMALE; GESTATIONAL AGE; GLYCINE; HUMANS; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE; MALE; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL;

EID: 84878275975     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2012-0293     Document Type: Article

References (37)

1. Braissant O, Henry H, Béard E, Uldry J. Creatine deficiency syndromes and the importance of creatine synthesis in the brain. Amino Acids 2011;40:1315 - 24.
2. Béard E, Braissant O. Synthesis and transport of creatine in the CNS: importance for cerebral functions. J Neurochem 2010;115:297 - 313.
3. Braissant O, Henry H, Villard AM, Speer O, Wallimann T, et al. Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1. BMC Dev Biol 2005;26:5 - 9.
4. Ireland Z, Russell AP, Wallimann T, Walker DW, Snow R. Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse. BMC Dev Biol 2009;9:39.
5. Kramer WB, Saade GR, Goodrum L, Montgomery L, Belfort M, et al. Neonatal outcome after active perinatal management of the very premature infant between 23 and 27 weeks'gestation. J Perinatol 1997;17:439- 43. (Pubitemid 127453417)
6. El-Metwally D, Vohr B, Tucker R. Survival and neonatal morbidity at the limits of viability in the mid 1990s: 22 to 25 weeks. J Pediatr 2000;137:616- 22.
7. Håkansson S, Farooqi A, Holmgren PA, Serenius F, Högberg U. Proactive management promotes outcome in extremely preterm infants: a population-based comparison of two perinatal management strategies. Pediatrics 2004;114:58 - 64. (Pubitemid 38857566)
8. Hack M, Fanaroff AA. Outcomes of children of extremely low birthweight and gestational age in the 1990s. Semin Neonatol 2000;5:89 - 106. (Pubitemid 30439012)
9. Marlow N, Wolke D, Bracewell MA. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 2005;352:9 - 19. (Pubitemid 40075676)
10. Arnaud C, Daubisse-Marliac L, White-Koning M, Pierrat V, Larroque B, et al. Prevalence and associated factors of minor neuromotor dysfunctions at age 5 years in prematurely born children: the EPIPAGE Study. Arch Pediatr Adolesc Med 2007;161:1053 - 61. (Pubitemid 350074837)
11. Pallás CR, Bustos G, Grupo PREVINFAD. El niño prematuro. Recomendaciones. Rev Pediatr Aten Primaria 2003;5:45 - 72.
12. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75 - 84.
13. Arpino C, Compagnone E, Montanaro ML, Cacciatore D, De Luca A, et al. Preterm birth and neurodevelopmental outcome: a review. Childs Nerv Syst 2010;26:1139 - 49.
14. de Vries AM, de Groot L. Transient dystonias revisited: a comparative study of preterm and term children at 2 1/2 years of age. Dev Med Child Neurol 2002;44:415 - 21. (Pubitemid 34661733)
15. da Silva ES, Nunes ML. The influence of gestational age and birth weight in the clinical assessment of the muscle tone of healthy term and preterm newborns. Arq Neuropsiquiatr 2005;63:956 - 62. (Pubitemid 43211529)
16. Farooqi A, Hägglöf B, Sedin G, Gothefors L, Serenius F. Chronic conditions, functional limitations, and special health care needs in 10- to 12-year-old children born at 23 to 25 weeks'gestation in the 1990s: a Swedish national prospective follow-up study. Pediatrics 2006;118:1466- 77.
17. Foulder-Hughes LA, Cooke RW. Motor, cognitive, and behavioural disorders in children born very preterm. Dev Med Child Neurol 2003;45:97- 103. (Pubitemid 36798206)
18. Hack M, Taylor HG, Drotar D, Schluchter M, Cartar L, et al. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. J Am Med Assoc 2005;294:318 - 25. (Pubitemid 41043775)
19. Rodríguez-Soriano J, Aguirre M, Oliveros R, Vallo A. Long-term renal follow-up of extremely low birth weight infants. Pediatr Nephrol 2005;20:579 - 84. (Pubitemid 41166610)
20. Bodamer OA, Bloesch SM, Gregg AR, Stockler-Ipsiroglu S, O'Brien WE. Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry. Clin Chim Acta 2001;308:173 - 8. (Pubitemid 32537623)
21. Gimenez M, Soria-Pastor S, Junque C, Caldu X, Narberhaus A, et al. Proton magnetic resonance spectroscopy reveals medial temporal metabolic abnormalities in adolescents with history of preterm birth. Pediatr Res 2008;64:572 - 7.
22. Kreis R, Hofmann L, Kuhlmann B, Boesch C, Bossi E, et al. Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 2002;48: 949 - 58. (Pubitemid 35398524)
23. Wu G, Jaeger LA, Bazer FW, Rhoads JM. Arginine deficiency in preterm infants: biochemical mechanisms and nutritional implications. J Nutr Biochem 2004;15:442 - 51. (Pubitemid 39118490)
24. Guignard JP, Drukker A. Why do newborn infants have a high plasma creatinine ? Pediatrics 1999;103:e49.
25. Verbruggen KT, Knijff WA, Soorani-Lunsing RJ, Sijens PE, Verhoeven NM, et al. Global developmental delay in guanidinoacetate methyltransferase deficiency: differences in formal testing and clinical observation. Eur J Pediatr 2007;166:921 - 5. (Pubitemid 47101345)
26. O'Rourke DJ, Ryan S, Salomons G, Jakobs C, Monavari A, et al. Guanidinoacetate methyltransferase (GAMT) deficiency: late onset of movement disorder and preserved expressive language. Dev Med Child Neurol 2009;51:404 - 7.
27. Verhoeven NM, Salomons GS, Jakobs C. Laboratory diagnosis of defects of creatine biosynthesis and transport. Clin Chim Acta 2005;361:1 - 9. (Pubitemid 41382605)
28. Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stöckler-Ipsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochim Pol 2004;51: 875 - 82. (Pubitemid 40187559)
29. Neu A, Neuhoff H, Trube G, Fehr S, Ullrich K, et al. Activation of GABA(A) receptors by guanidinoacetate: a novel pathophysio-logical mechanism. Neurobiol Dis 2002;11:298 - 307. (Pubitemid 36135693)
30. Schulze A, Ebinger F, Rating D, Mayatepek E. Improving treatment of guanidinoacetate methyltransferase deficiency: reduction of guanidinoacetic acid in body fluids by arginine restriction and ornithine supplementation. Mol Genet Metab 2001;74:413 - 9. (Pubitemid 34084650)
31. Hiramatsu M, Ohba S, Edamatsu R, Kadowari D, Mori A. Effect of guanidino compounds on membrane fluidity of rat synaptosomes. In: De Deyn PP, Marescau IA, Quereshi SD, Mori A, editors. Guanidino compounds in biology and medicine. Guildford: John Libbey & Company Lta, 1992:387 - 93.
32. Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, et al. Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 2001;388:261 - 6. (Pubitemid 32911618)
33. Zugno AI, Stefanello FM, Scherer EB, Mattos C, Pederzolli CD, et al. Guanidinoacetate decreases antioxidant defenses and total protein sulfhydryl content in striatum of rats. Neurochem Res 2008;33:1804 - 10.
34. Zugno AI, Scherer EB, Schuck PF, Oliveira DL, Wofchuk S, et al. Intrastriatal administration of guanidinoacetate inhibits Na +, K + -ATPase and creatine kinase activities in rat striatum. Metab Brain Dis 2006;21:41 - 50. (Pubitemid 43886892)
35. Toft PB, Leth H, Lou HC, Pryds O, Henriksen O. Metabolite concentrations in the developing brain estimated with proton MR spectroscopy. J Magn Reson Imaging 1994;4:674 - 80.
36. Holtzman D, Togliatti A, Khait I, Jensen F. Creatine increases survival and suppresses seizures in the hypoxic immature rat. Pediatr Res 1998;44:410- 4. (Pubitemid 28390000)
37. Ireland Z, Dickinson H, Snow R, Walker DW. Maternal creatine: does it reach the fetus and improve survival after an acute hypoxic episode in the spiny mouse (Acomys cahirinus) ? Am J Obstet Gynecol 2008;198:431.e1 - 6.